Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: SKYEY - SkyePharma PLC

No earlier versions found for this Subject.

Return to SKYEY - SkyePharma PLC

SkyePharma is a rapidly growing British biotechnology company specializing in drug delivery technologies. It is listed on the London Stock Exchange as SKP. Its American depository receipts are listed on the NASDAQ as SKYEY. Each depository reciept is the equivalent of 10 shares of SKP.

I became interested in SKYEY as a result of their merger with DepoTech, DEPO. Since, DEPO is now a subsidiary of SkyePharma and no longer traded, I thought that there was a need for an open discussion thread of SKYEY.